| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.18B | 59.25B | 59.21B | 55.23B | 48.12B | 37.27B |
| Gross Profit | 40.54B | 39.31B | 37.67B | 35.15B | 29.67B | 24.45B |
| EBITDA | 8.88B | 8.63B | 9.63B | 6.59B | 6.12B | 3.55B |
| Net Income | 4.41B | 4.20B | 4.68B | 3.17B | 2.07B | 486.00M |
Balance Sheet | ||||||
| Total Assets | 45.75B | 42.88B | 43.62B | 36.34B | 31.57B | 30.06B |
| Cash, Cash Equivalents and Short-Term Investments | 22.51B | 18.92B | 20.64B | 17.92B | 17.70B | 11.01B |
| Total Debt | 14.75B | 11.27B | 12.68B | 9.76B | 5.78B | 6.77B |
| Total Liabilities | 24.89B | 21.54B | 23.64B | 20.58B | 15.39B | 15.20B |
| Stockholders Equity | 16.30B | 17.09B | 16.18B | 12.95B | 12.37B | 11.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.50B | 3.55B | 950.00M | 3.78B | 1.59B |
| Operating Cash Flow | 0.00 | 5.67B | 4.45B | 1.46B | 4.67B | 2.13B |
| Investing Cash Flow | 0.00 | -1.45B | -1.15B | -1.29B | -1.00B | 644.37M |
| Financing Cash Flow | 0.00 | -2.92B | -882.00M | -358.00M | -1.06B | 209.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥60.09B | 7.15 | 30.38% | 2.74% | 6.18% | 2.73% | |
78 Outperform | ¥14.67B | 10.54 | ― | 2.22% | 26.29% | 28.62% | |
65 Neutral | ¥1.01T | 17.87 | 49.14% | 2.82% | 6.80% | 0.62% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | ¥44.59B | 20.81 | 14.53% | 0.21% | 23.01% | 34.28% | |
56 Neutral | ¥32.91B | 39.85 | ― | 0.82% | 49.28% | -117.98% | |
41 Neutral | ¥1.62T | -12.21 | -21.14% | ― | 11.45% | 42.34% |